SG&A at other companies
Other financials
Where this comes from
Reported directly by Orthofix Medical Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Orthofix Medical Inc.'s sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Orthofix Medical Inc.'s SG&A?
- Orthofix Medical Inc. (OFIX) reported SG&A of $134.91M in Q1 2026.
- How has Orthofix Medical Inc.'s SG&A changed year-over-year?
- Orthofix Medical Inc.'s SG&A increased by 1.5% year-over-year, from $132.98M to $134.91M.
- What is the long-term trend for Orthofix Medical Inc.'s SG&A?
- Over 3 years (2022 to 2025), Orthofix Medical Inc.'s SG&A has grown at a 21.5% compound annual growth rate (CAGR), from $308.78M to $554.33M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.